Increased Oxidative Damage in Carriers of the Germline TP53 p.R337H Mutation
暂无分享,去创建一个
P. Hainaut | F. Klamt | C. Vargas | P. Ashton-Prolla | C. Netto | V. Manfredini | G. Macedo | J. Giacomazzi | L. Lisbôa da Motta | Camila S.Vanzin
[1] A. Mancuso,et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase , 2011, Nature Cell Biology.
[2] A. Levine,et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function , 2010, Proceedings of the National Academy of Sciences.
[3] M. Olivier,et al. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect , 2010, Human mutation.
[4] D. Meek. Tumour suppression by p53: a role for the DNA damage response? , 2009, Nature Reviews Cancer.
[5] Kevin M. Ryan,et al. p53 and metabolism , 2009, Nature Reviews Cancer.
[6] S. Sommer,et al. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] S. Narod,et al. A BRCA1 mutation is not associated with increased indicators of oxidative stress. , 2008, Clinical breast cancer.
[8] S. Shurtleff,et al. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil , 2008, BMC Cancer.
[9] M. Olivier,et al. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. , 2008, Cancer letters.
[10] B. Halliwell,et al. Biochemistry of oxidative stress. , 2007, Biochemical Society transactions.
[11] M. Olivier,et al. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. , 2007, Cancer letters.
[12] H. Bartsch,et al. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair , 2006, Langenbeck's Archives of Surgery.
[13] C. Prives,et al. Transcriptional regulation by p53: one protein, many possibilities , 2006, Cell Death and Differentiation.
[14] P. Chumakov,et al. The antioxidant function of the p53 tumor suppressor , 2005, Nature Medicine.
[15] E. Koonin,et al. Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.
[16] M. Armoni,et al. The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.
[17] Leah E. Mechanic,et al. p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis , 2004, Cancer Research.
[18] Yusuke Nakamura,et al. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses , 2004, Journal of Human Genetics.
[19] R. Eeles,et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. , 2003, Cancer research.
[20] Roberto Colombo,et al. Protein carbonyl groups as biomarkers of oxidative stress. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[21] E. Pinto,et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. , 2001, The Journal of clinical endocrinology and metabolism.
[22] J. Varley,et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations , 2001, Oncogene.
[23] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[24] M. Swaroop,et al. Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53* , 1999, The Journal of Biological Chemistry.
[25] C. Harris,et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Rice-Evans,et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. , 1993, Clinical science.
[27] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[28] W. Blattner,et al. A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.
[29] I. Fridovich,et al. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. , 1972, The Journal of biological chemistry.
[30] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[31] J. Garber,et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. , 2006, Gastroenterology.
[32] M. Karatepe. Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC-UV , 2004 .
[33] R. Ribeiro,et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.
[34] P. Hainaut. Tumor-specific mutations in p53: The acid test , 2002, Nature Medicine.
[35] W. Mcdougal. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.
[36] S. Ameshima,et al. [Glutathione peroxidase]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.
[37] E. Stadtman,et al. Determination of carbonyl content in oxidatively modified proteins. , 1990, Methods in enzymology.
[38] P. Kovacic. Free Radicals in Biology and Medicine , 1986 .
[39] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.
[40] A. Wendel. [44] Glutathione peroxidase , 1981 .